Document is current
Any future updates will be listed below
-
Authors
Tu, Che-Chang
Chen, Ming-Hsu
Lan, Guan-Yu
Lin, Yu-Ting
Lin, Yu-Tse
Tai, Wei-Chiu
Yu, Jiashing
Chang, Po-Chun
-
Funding
Funding for this research was provided by:
National Science and Technology Council (113-2314-B-002-039)
National Science and Technology Council (110-2314-B-002-109-MY3)
National Science and Technology Council (113-2314-B-002-039)
National Science and Technology Council (110-2314-B-002-109-MY3)
National Taiwan University Hospital (112-CGN0004)
National Taiwan University Hospital (112-CGN0004)
- License Information
-
More Information
Article History
Received: 9 June 2025
Accepted: 1 September 2025
First Online: 29 September 2025
Declarations
:
: All procedures performed on animals were approved by the Animal Care and Use Committee of National Taiwan University (project title: ‘allogenic gingival stem cell as a potential modality for treating mucosal and osseous wounds in jaws affected by medication-related osteonecrosis’; protocol no: 20201244; approved date: January 27, 2021) and were conducted in accordance with ARRIVE guidelines. The procedures for gene recombination were approved by the Committee of Biological Safety of National Taiwan University Hospital.
: Not applicable.
: The authors declare no competing interests.
